AHDC1 Inhibitors
AHDC1 inhibitors represent a specific class of chemical compounds designed to modulate the activity of the AT-hook DNA-binding motif containing 1 (AHDC1) protein, which plays a key role in the regulation of gene expression and chromatin remodeling. AHDC1 is a nuclear protein characterized by its AT-hook motifs, which are small peptide sequences capable of binding to the minor groove of AT-rich DNA regions. This interaction allows AHDC1 to influence various cellular processes such as transcription, DNA repair, and chromatin structure maintenance. Inhibitors of AHDC1 typically work by disrupting its interaction with DNA or by altering the protein's conformational structure, thereby reducing its ability to participate in gene regulation. As AHDC1 is involved in chromatin dynamics and gene transcription, its inhibitors hold significance for researchers focused on understanding the molecular mechanisms of chromatin architecture and gene expression regulation.
The design and development of AHDC1 inhibitors often involve small molecules that target the AT-hook motifs or other structural domains essential for the protein's function. These inhibitors can be categorized based on their mode of action, such as competitive inhibitors that block the DNA-binding site or allosteric inhibitors that induce conformational changes in the protein. Through targeted disruption of AHDC1's function, these inhibitors serve as valuable tools for studying the complex interplay between chromatin structure and gene regulation. In experimental settings, AHDC1 inhibitors may provide insights into the biological roles of AT-hook DNA-binding proteins, particularly in relation to chromatin accessibility, transcriptional activation or repression, and the broader epigenetic landscape.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that gets incorporated into RNA and DNA. It inhibits DNA methyltransferase, leading to hypomethylation of DNA. As AHDC1 is potentially involved in chromatin modification, altering methylation can impact its interaction with DNA. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
An analog of cytidine that inhibits DNA methyltransferase. It results in DNA hypomethylation, affecting chromatin structure and potentially modulating AHDC1's interactions or binding efficiency with DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An organic compound that inhibits histone deacetylases (HDAC). By influencing histone acetylation levels, it affects chromatin structure. This alteration in chromatin can indirectly modulate AHDC1's function or interaction with chromatin. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A HDAC inhibitor, it impacts histone acetylation levels. By changing the chromatin structure, AHDC1's ability to interact or bind with chromatin may be indirectly affected. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another HDAC inhibitor, affecting histone acetylation. Alters chromatin structure, potentially influencing AHDC1's DNA binding properties or interactions. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Inhibits HDAC, changing histone acetylation patterns. Changes in chromatin structure can indirectly modulate AHDC1's function or its chromatin interactions. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A fatty acid that acts as an HDAC inhibitor. By affecting chromatin structure through changes in histone acetylation, AHDC1's interaction with chromatin may be modulated indirectly. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
A HDAC inhibitor, it impacts histone acetylation. By influencing chromatin conformation, AHDC1's binding or interaction dynamics with chromatin can be affected. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A bromodomain inhibitor, JQ1 affects the reading of acetylated histones. By influencing protein interactions with acetylated histones, it can alter chromatin-associated processes, potentially affecting the functionality or dynamics of AHDC1. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Bromodomain inhibitor that affects proteins' ability to read acetylated histones. Influencing these interactions can impact chromatin structure or dynamics, which might indirectly influence AHDC1's chromatin interactions. | ||||||